Teleflex Incorporated (NYSE:TFX) shot up 0.6% during mid-day trading on Thursday . The company traded as high as $227.92 and last traded at $226.66. 205,015 shares were traded during trading, a decline of 13% from the average session volume of 236,625 shares. The stock had previously closed at $225.41.

A number of brokerages have recently issued reports on TFX. KeyCorp reaffirmed a “hold” rating on shares of Teleflex in a research report on Wednesday. Jefferies Group LLC reaffirmed a “buy” rating and set a $230.00 target price on shares of Teleflex in a research report on Thursday, August 3rd. BidaskClub lowered Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday, August 8th. Zacks Investment Research lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Thursday, August 31st. Finally, Needham & Company LLC boosted their target price on Teleflex from $228.00 to $237.00 and gave the stock a “buy” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. Teleflex has an average rating of “Buy” and a consensus price target of $230.83.

The firm’s 50-day moving average is $210.65 and its 200-day moving average is $202.16. The firm has a market cap of $10.23 billion, a PE ratio of 43.44 and a beta of 1.05.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.13. The business had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. Teleflex’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.89 earnings per share. On average, equities research analysts predict that Teleflex Incorporated will post $8.28 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s payout ratio is currently 26.00%.

In other Teleflex news, Director Gretchen R. Haggerty purchased 1,000 shares of Teleflex stock in a transaction that occurred on Wednesday, June 21st. The stock was acquired at an average price of $203.82 per share, for a total transaction of $203,820.00. Following the completion of the acquisition, the director now owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $211.75, for a total value of $42,350.00. Following the transaction, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The disclosure for this sale can be found here. Insiders have sold 600 shares of company stock valued at $125,652 in the last quarter. 2.39% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of TFX. Janney Montgomery Scott LLC grew its holdings in Teleflex by 25.5% during the first quarter. Janney Montgomery Scott LLC now owns 2,193 shares of the medical technology company’s stock worth $425,000 after purchasing an additional 445 shares during the period. Livforsakringsbolaget Skandia Omsesidigt bought a new position in Teleflex during the first quarter worth about $155,000. Strs Ohio grew its holdings in Teleflex by 2,354.8% during the first quarter. Strs Ohio now owns 15,637 shares of the medical technology company’s stock worth $3,029,000 after purchasing an additional 15,000 shares during the period. DUPONT CAPITAL MANAGEMENT Corp bought a new position in Teleflex during the first quarter worth about $601,000. Finally, Sumitomo Mitsui Asset Management Company LTD grew its holdings in Teleflex by 14.7% during the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 3,543 shares of the medical technology company’s stock worth $686,000 after purchasing an additional 454 shares during the period. Institutional investors and hedge funds own 90.50% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.dailypolitical.com/2017/09/07/teleflex-incorporated-tfx-shares-up-0-6.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.